The invention refers to new alkylating di- and tripeptides based on a melphalan unit, and one or two additional amino acids or amino acid derivatives, which can be used in the treatment of carcinogenic diseases. Further, the invention refers to a pharmaceutical composition comprising the alkylating peptides of the invention.

 
Web www.patentalert.com

< Compounds and methods for inhibiting MRP1

< Electromagnetic interference immune tissue invasive system

> Modafinil polymorphic forms

> Imaging system for examining biological material

~ 00235